John Inge Johnsen Selected Research

John Inge Johnsen Research Topics

Disease

50	Neoplasms (Cancer) 02/2024 - 08/2006
39	Neuroblastoma 02/2024 - 04/2003
14	Medulloblastoma 04/2022 - 10/2008
4	Carcinogenesis 03/2022 - 01/2010
4	Brain Neoplasms (Brain Tumor) 08/2012 - 10/2008
3	Inflammation (Inflammations) 11/2022 - 01/2012
1	Neoplasm Metastasis (Metastasis) 02/2024
1	Breast Neoplasms (Breast Cancer) 11/2022
1	Carcinoma (Carcinomatosis) 11/2022
1	Merkel Cell Carcinoma 03/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Nervous System Neoplasms (Neoplasms, Nervous System) 01/2020
1	Rhabdomyosarcoma 01/2019

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 02/2019 - 07/2010
8	RNA (Ribonucleic Acid)IBA 02/2024 - 10/2011
6	Dinoprostone (PGE2)FDA Link 04/2022 - 10/2008
4	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 04/2022 - 05/2006
4	Phosphotransferases (Kinase)IBA 01/2022 - 01/2010
4	Prostaglandin-E SynthasesIBA 01/2020 - 10/2008
4	Small Interfering RNA (siRNA)IBA 02/2019 - 11/2009
4	DNA (Deoxyribonucleic Acid)IBA 08/2014 - 10/2011
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 05/2006
3	rho-Associated KinasesIBA 12/2019 - 03/2016
3	CalciumIBA 11/2017 - 01/2012
3	CateninsIBA 03/2016 - 11/2015
3	ProstaglandinsIBA 01/2012 - 10/2008
3	Prostaglandins EIBA 01/2012 - 10/2008
3	Docosahexaenoic AcidsIBA 04/2011 - 05/2006
2	Long Noncoding RNAIBA 01/2024 - 01/2021
2	Transcription Factors (Transcription Factor)IBA 09/2023 - 01/2020
2	CytokinesIBA 03/2022 - 11/2017
2	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 11/2015
2	Messenger RNA (mRNA)IBA 12/2019 - 01/2012
2	ChemokinesIBA 11/2017 - 01/2016
2	Complementary DNA (cDNA)IBA 03/2016 - 01/2016
2	Macrophage Colony-Stimulating FactorIBA 01/2016 - 01/2016
2	4- (2- (2- hydroxycyclohexylamino)benzothiazol- 6- yloxy)pyridine- 2- carboxylic acid methylamideIBA 01/2016 - 01/2016
2	MethyltransferasesIBA 11/2015 - 08/2014
2	Antiviral Agents (Antivirals)IBA 02/2015 - 10/2011
2	Imatinib Mesylate (Gleevec)FDA Link 08/2014 - 03/2009
2	4-phenylbutyric acid (Buphenyl)FDA Link 08/2014 - 07/2011
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2014 - 07/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 10/2011
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2012 - 10/2008
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2012 - 10/2011
2	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2011 - 01/2010
2	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 04/2011 - 03/2010
2	LipidsIBA 03/2010 - 10/2005
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 05/2006 - 10/2005
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2006 - 10/2005
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2024
1	InterferonsIBA 11/2022
1	eprenetapoptIBA 11/2022
1	alpha-Linolenic Acid (Linolenic Acid)IBA 04/2022
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 04/2022
1	Tumor Viral Antigens (Large T Antigen)IBA 03/2022
1	Dihydroorotate DehydrogenaseIBA 01/2022
1	brequinarIBA 01/2022
1	Anaplastic Lymphoma KinaseIBA 01/2022
1	entrectinibIBA 01/2022
1	TropomyosinIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 12/2021
1	SL-176IBA 11/2021
1	nutlin 3IBA 11/2021
1	Vincristine (Oncovin)FDA LinkGeneric 01/2020
1	Galectin 1 (LGALS1)IBA 01/2020
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2020
1	HhAntag691IBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	RKI-1447IBA 12/2019
1	Syk KinaseIBA 02/2019
1	CX 5461IBA 01/2019
1	GANT 61IBA 01/2019
1	NSC 652287IBA 01/2019
1	RNA Polymerase I (Polymerase I, RNA)IBA 01/2019
1	Aurora KinasesIBA 01/2017
1	Checkpoint Kinase 1IBA 01/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	CalcineurinIBA 01/2016
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2016
1	Estrogen Receptor alphaIBA 01/2016
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2016
1	Therapeutic UsesIBA 01/2016
1	Phospho-Specific AntibodiesIBA 01/2016
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	cyclosporin HIBA 01/2016
1	Blocking AntibodiesIBA 01/2016
1	DNA Repair EnzymesIBA 11/2015
1	tyrosine receptor (receptor, tyrosine)IBA 08/2014
1	Histones (Histone)IBA 08/2014
1	Sunitinib (Sutent)FDA Link 01/2014

Therapy/Procedure

25	Therapeutics 09/2023 - 04/2003
6	Drug Therapy (Chemotherapy) 02/2024 - 10/2005
1	Investigational Therapies (Experimental Therapy) 01/2017
1	Immunotherapy 01/2016
1	Combined Modality Therapy 01/2016
1	Heterologous Transplantation (Xenotransplantation) 01/2016